Wednesday, November 04, 2009

Marc Siegel H1N1 Government Failed

Siegel on Fox: CDC Almost all cases of flu right now are H1N1.

Not as many doses of the vaccine as originally touted, Siegel stated. FDA also didn't "approve" the latest technology in vaccine development... those have actually been "shipped overseas!"

That is interesting because the question becomes, of the latest vaccine, going unused or unprovided in U.S. did the taxpayers fund any, any of these by way of funding the production in the U.S.?...

Has the U.S. funded the companies producing the vaccine outside the U.S.?

Let's see. Federal government contracts with 5 manufacturers who've supplied the 'seasonal flu' vaccine in the past. But doesn't give some of them the ok to supply the U.S.? Why not?

We agreewith Siegel, the federal government failed to deliver.

But unfortunately, Siegel appeared to blame 'scaremongers' and lumps in with the 'out there' with those who have serious concerns because of key factors in the production.

Noted among those is the companies are exempt from litigation/lawsuits if something goes sereiously wrong in the way of 'side effects.'

Deaths, for instance, which could be directly attributed to the flu vaccine.

Another notable concern is the use of squaline and thimerosal as ingredients in particular the multi-dose vaccines.

There are additional concerns, such as mandated or forced vaccination, and oh, the declaration of a national emergency by President Barack Obama (which many could argue would lead to more than a mandate, but actual segregation of the unvaccinated.

Yet, as of today, there are not enough doses to provide the vaccine even to those who desire to take the vaccine, whichever form, single or multiple dose!

Net the Truth Online

H1N1 vaccine makers struggle with U.S. shot
One company still waiting for approval, others have production issues
updated 2:49 p.m. ET, Tues., Oct . 27, 2009
WASHINGTON - GlaxoSmithKline has yet to get U.S. government approval for its swine flu vaccine, the company said on Tuesday, while Novartis said it was still struggling to make vaccines.

A U.S. senator accused the Health and Human Services department of over-promising how many and how quickly H1N1 vaccines could be delivered, as disgruntled people lined up outside clinics across the United States seeking immunization.

The United States has contracted with its five suppliers of seasonal influenza vaccine to also deliver H1N1 vaccine, but has sharply cut initial estimates of how much will be delivered this month and next...

Related Not Endorsements

Flu symptoms test

New Scientist History

No comments: